Skip to main content

Familial Colorectal Cancer

  • Chapter
Progress in Colorectal Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dunlop MG. Colorectal cancer genetics. Semin Cancer Biol. 1992;3:131–140.

    PubMed  CAS  Google Scholar 

  2. Cairns S, Scholefield JH. Guidelines for colorectal cancer screening in high risk groups. Gut 2002; 51(suppl 5):V1–V2.

    PubMed  Google Scholar 

  3. Sharma VK, Vasudeva R, Howden CW. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gastroenterol. 2000;95:1551–1556.

    PubMed  CAS  Google Scholar 

  4. Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002;97:729–733.

    Article  PubMed  Google Scholar 

  5. Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 1994;3:121–125.

    Article  PubMed  CAS  Google Scholar 

  6. Burn J, Chapman PD, Eastham EJ. Familial adenomatous polyposis. Arch Dis Child. 1994;71: 103–105.

    PubMed  CAS  Google Scholar 

  7. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980–1982.

    PubMed  CAS  Google Scholar 

  8. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783–785.

    PubMed  CAS  Google Scholar 

  9. Bertario L, Bandello F, Rossetti C, et al. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Eur J Cancer Prev. 1993;2:69–75.

    PubMed  CAS  Google Scholar 

  10. Chapman PD, Church W, Burn J, Gunn A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. BMJ. 1989;29:353–354.

    Google Scholar 

  11. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377–381.

    PubMed  CAS  Google Scholar 

  12. Mandl M, Paffenholz R, Friedl W, Caspari R, Sengteller M, Propping P. Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet. 1994;3: 181–184.

    PubMed  CAS  Google Scholar 

  13. Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1996;24:121–124.

    PubMed  CAS  Google Scholar 

  14. van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res. 2001;264:126–134.

    PubMed  Google Scholar 

  15. Seidensticker MJ, Behrens J. Biochemical interactions in the wnt pathway. Biochim Biophys Acta. 2000;1495:168–182.

    PubMed  CAS  Google Scholar 

  16. Neufeld KL, Zhang F, Cullen BR, White RL. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep. 2000;1:519–523.

    PubMed  CAS  Google Scholar 

  17. Friedl W, Meuschel S, Caspari R, et al. Attenuated familial adenomatous polyposis due to a mutation in the 3″ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet. 1996; 97:579–584.

    Article  PubMed  CAS  Google Scholar 

  18. Samowitz WS, Thliveris A, Spirio LN, White R. Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Cancer Res. 1995;55:3732–3734.

    PubMed  CAS  Google Scholar 

  19. Nugent KP, Phillips RK, Hodgson SV, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 1994;35:1622–1623.

    PubMed  CAS  Google Scholar 

  20. Bunyan DJ, Shea-Simonds J, Reck AC, Finnis D, Eccles DM. Genotypephenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposis. J Med Genet. 1995;32:728–731.

    Article  PubMed  CAS  Google Scholar 

  21. Wallis YL, Macdonald F, Hulten M, et al. Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet. 1994;94:543–548.

    Article  PubMed  CAS  Google Scholar 

  22. Houlston R, Crabtree M, Phillips R, Crabtree M, Tomlinson I. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut 2001;48:1–5.

    Article  PubMed  CAS  Google Scholar 

  23. Caspari R, Friedl W, Mandl M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994;343:629–632.

    Article  PubMed  CAS  Google Scholar 

  24. Michie S, Bobrow M, Marteau TM. Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet. 2001;38:519–526.

    Article  PubMed  CAS  Google Scholar 

  25. De Cosse JJ, Bulow S, Neale K, et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg. 1992;79:1372–1375.

    PubMed  Google Scholar 

  26. Nugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg. 1992;79:1204–1206.

    PubMed  CAS  Google Scholar 

  27. Spigelman A, Phillips R. Surveillance of the duodenum in patients with familial adenomatous polyposis. Gut 1998;4:144–145.

    Google Scholar 

  28. Bresalier RS. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis. Gastroenterology 2000;119:1797–1798.

    PubMed  CAS  Google Scholar 

  29. Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 2001;61:1733–1740.

    PubMed  CAS  Google Scholar 

  30. Dobbie Z, Muller PY, Heinimann K, et al. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam. Anticancer Res. 2002;22:2215–2220.

    PubMed  CAS  Google Scholar 

  31. Lamlum H, Al Tassan N, Jaeger E, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet. 2000;9:2215–2221.

    PubMed  CAS  Google Scholar 

  32. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA. 1998;95:10722–10727.

    Article  PubMed  CAS  Google Scholar 

  33. Al Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232.

    Google Scholar 

  34. Popat S, Stone J, Coleman G, et al. Prevalence of the APC E1317Q variant in colorectal cancer patients. Cancer Lett. 2000;149:203–206.

    Article  PubMed  CAS  Google Scholar 

  35. Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet. 1996; 5:1489–1494.

    PubMed  CAS  Google Scholar 

  36. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 1997;57:3920–3923.

    PubMed  CAS  Google Scholar 

  37. Lazar V, Grandjouan S, Bognel C, et al. Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet. 1994;3:2257–2260.

    PubMed  CAS  Google Scholar 

  38. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996;111:307–317.

    PubMed  CAS  Google Scholar 

  39. Moslein G, Tester DJ, Lindor NM, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet. 1996;5:1245–1252.

    Article  PubMed  CAS  Google Scholar 

  40. Aaltonen LA. Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. Recent results. Cancer Res. 1998;154:306–311.

    CAS  Google Scholar 

  41. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg. 1998;2: 67–71.

    Article  PubMed  CAS  Google Scholar 

  42. Pensotti V, Radice P, Presciuttini S, et al. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer [HNPCC] families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosomes Cancer. 1997;19:135–142.

    Article  PubMed  CAS  Google Scholar 

  43. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69–77.

    Article  PubMed  CAS  Google Scholar 

  44. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–110.

    Article  PubMed  CAS  Google Scholar 

  45. Planck M, Rambech E, Moslein G, et al. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum. Cancer 2002; 94:2502–2510.

    Article  PubMed  CAS  Google Scholar 

  46. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90:606–613.

    PubMed  CAS  Google Scholar 

  47. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot’s syndrome. N Engl J Med. 1995;332:839–847.

    Article  PubMed  CAS  Google Scholar 

  48. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary nonpolyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002;51(suppl 5): V21–V27.

    PubMed  Google Scholar 

  49. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary nonpolyposis colorectal cancer [Lynch syndrome]. Lancet 1995;345:1183–1184.

    Article  PubMed  CAS  Google Scholar 

  50. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829–834.

    Article  PubMed  CAS  Google Scholar 

  51. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science 1996; 274:621–624.

    PubMed  CAS  Google Scholar 

  52. Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med. 1996;28:479–482.

    Article  PubMed  CAS  Google Scholar 

  53. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997;225: 202–207.

    Article  PubMed  CAS  Google Scholar 

  54. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer [HNPCC] syndrome. Int J Cancer. 1995;64:430–433.

    PubMed  CAS  Google Scholar 

  55. Giardiello FM, Offerhaus JG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer. 1995;31A:1085–1087.

    PubMed  CAS  Google Scholar 

  56. Hemminki K, Li X. Familial colorectal adenocarcinoma from the Swedish Family-Cancer Database. Int J Cancer. 2001;94:743–748.

    PubMed  CAS  Google Scholar 

  57. Boardman LA, Pittelkow MR, Couch FJ, et al. Association of Peutz-Jegherslike mucocutaneous pigmentation with breast and gynecologic carcinomas in women. Medicine (Baltimore). 2000;79(5):293–298.

    CAS  Google Scholar 

  58. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol. 1998;5:751–756.

    PubMed  CAS  Google Scholar 

  59. Woodford-Richens K, Bevan S, Churchman M, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 2000;46:656–660.

    Article  PubMed  CAS  Google Scholar 

  60. Eng C. Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol. 1998; 12:701–710.

    PubMed  CAS  Google Scholar 

  61. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet. 2002;11:2961–2967.

    PubMed  CAS  Google Scholar 

  62. Ohtsubo T, Nishioka K, Imaiso Y, et al. Identification of human MutY homolog [hMYH] as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res. 2000;28:1355–1364.

    Article  PubMed  CAS  Google Scholar 

  63. Hayashi H, Tominaga Y, Hirano S, McKenna AE, Nakabeppu Y, Matsumoto Y. Replication-associated repair of adenine:8-oxoguanine mispairs by MYH. Curr Biol. 2002;12:335–339.

    Article  PubMed  CAS  Google Scholar 

  64. Dunlop MG. Colorectal cancer. BMJ. 1997;314:1882–1885.

    PubMed  CAS  Google Scholar 

  65. Bishop DT, Hall NR. The genetics of colorectal cancer. Eur J Cancer. 1994; 30A:1946–1956.

    PubMed  CAS  Google Scholar 

  66. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:195–197.

    Google Scholar 

  67. Lynch HT, Paulson J, Severin M, Lynch J, Lynch P. Failure to diagnose hereditary colorectal cancer and its medicolegal implications: a hereditary nonpolyposis colorectal cancer case. Dis Colon Rectum. 1999;42: 31–35.

    PubMed  CAS  Google Scholar 

  68. Eaden JA, Maybery JF. Guidelines for screening and surveillance of asyptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(suppl 5):V10–V12.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag London Limited

About this chapter

Cite this chapter

Dolwani, S., Sampson, J.R. (2005). Familial Colorectal Cancer. In: Beynon, J., Carr, N.D. (eds) Progress in Colorectal Surgery. Springer, London. https://doi.org/10.1007/1-84628-058-3_3

Download citation

  • DOI: https://doi.org/10.1007/1-84628-058-3_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-823-7

  • Online ISBN: 978-1-84628-058-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics